RISK FACTORS FOR SKELETAL-RELATED EVENTS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER PATIENTS WITH BONE METASTASES

被引：0
|
作者：
Ulas, A. [1 ]
Bilici, A. [2 ]
Tokluoglu, S. T. [3 ]
Akinci, S. [4 ]
Silay, K. [5 ]
Turkoz, F. Paksoy [6 ]
Durnali, A. [3 ]
Oksuzoglu, B. O. [3 ]
Alkis, N. [3 ]
机构：
[1] Ankara Ataturk Res & Teaching Hosp, Dept Med Oncol, Ankara, Turkey
[2] Medipol Mega Hosp Complex Univ Hosp, Med Oncol, Istanbul, Turkey
[3] Dr Abdurrahman Yurtaslan Ankara Onkol Training &, Dept Med Oncol, Ankara, Turkey
[4] Ankara Ataturk Res & Teaching Hosp, Dept Hematol, Ankara, Turkey
[5] Ankara Ataturk Res & Teaching Hosp, Dept Internal Med, Ankara, Turkey
[6] Ataturk Chest Dis & Chest Surg Educ & Res Hosp, Med Oncol, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv050.41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Re: “Prediction of skeletal-related events in patients with non-small cell lung cancer”—use of Spine Instability Neoplastic Score (SINS)
    Estanislao Arana
    Francisco M. Kovacs
    Ana Royuela
    Beatriz Asenjo
    Úrsula Pérez-Ramírez
    Javier Zamora
    Supportive Care in Cancer, 2016, 24 : 3273 - 3274
  • [32] Statins may decrease skeletal-related events in breast cancer patients with bone metastases
    Dincer, Murat
    Bulut, Nilufer
    Harputluoglu, Hakan
    Altundag, Kadri
    MEDICAL HYPOTHESES, 2006, 67 (05) : 1146 - 1147
  • [33] Clinical and economic impact of skeletal-related events in breast cancer patients with bone metastases
    Carter, J.
    Kaura, S.
    Botteman, M.
    BREAST, 2011, 20 : S78 - S78
  • [34] Bone disease progression (BDP) is associated with significantly increased risk of skeletal-related events (SREs) in patients with advanced solid tumors including non-small cell lung cancer (NSCLC)
    Tchekmedyian, Simon N.
    Chen, Yin-Miao
    Hirsh, Vera
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S543 - S543
  • [35] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [36] Risk of skeletal-related events (SREs) in patients with breast cancer (BC) and newly diagnosed metastases to bone.
    Taneja, Charu
    Lamerato, Lois
    Glass, Andrew
    Richert-Boe, Kathryn E.
    Edelsberg, John
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Risk of skeletal-related events (SREs) in patients with prostate cancer (PC) and newly diagnosed metastases to bone.
    Glass, Andrew
    Lamerato, Lois
    Edelsberg, John
    Richert-Boe, Kathryn E.
    Taneja, Charu
    Wolff, Greg G.
    Czapski, Natalie
    Chung, Karen
    Richhariya, Akshara
    Oster, Gerry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [38] Intravenous and oral ibandronate reduce the risk of skeletal-related events (SREs) in patients with breast cancer and bone metastases
    Tripathy, D.
    Body, J. -J.
    Die, I. J.
    Bergstrom, B.
    EJC SUPPLEMENTS, 2004, 2 (03): : 138 - 138
  • [39] Bone Pain, Skeletal-Related Events and Opioid Analgesic Use in Prostate Cancer Patients with Bone Metastases
    Valderrama, Adriana
    Eapen, Sara
    Hennessey, Kelly A.
    Jones, Casey
    Wen, Lonnie
    Germino, Joseph
    Duh, Mei S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 473 - 473
  • [40] Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases
    Hagiwara, M.
    Delea, T. E.
    Saville, M. W.
    Chung, K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (01) : 23 - 27
12345